Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Favorable preclinical results for huN901-DM1/BB-10901 support rapid advance to clinic

Dec. 1, 2000

CRC describes new prodrugs for cancer ADEPT or GDEPT

Dec. 1, 2000

Positive preliminary response rate reported for RSR-13 in NSCLC

Dec. 1, 2000

Bristol-Myers Squibb seeks FDA approval to begin systemic CA4P trials

Dec. 1, 2000

Abgenix and Immunex join forces for development of anticancer antibodies

Dec. 1, 2000

Scotia submits additional data to FDA for Foscan NDA

Nov. 30, 2000

U.K. scientists investigate novel series of antitumor agents

Nov. 30, 2000

Maxim receives SBIR grant for development of caspase-inducing drugs

Nov. 30, 2000

FeRx and Elan to develop MTC-DOX for treatment of liver cancer

Nov. 30, 2000

Deltagen obtains license to develop potential AML treatment

Nov. 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...